Page last updated: 2024-10-31

mianserin and Disorder, Borderline Personality

mianserin has been researched along with Disorder, Borderline Personality in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gentile, S1
Montgomery, SA1
Roy, D1
Montgomery, DB1

Trials

1 trial available for mianserin and Disorder, Borderline Personality

ArticleYear
The prevention of recurrent suicidal acts.
    British journal of clinical pharmacology, 1983, Volume: 15 Suppl 2

    Topics: Adult; Borderline Personality Disorder; Depressive Disorder; Dibenzazepines; Female; Histrionic Pers

1983

Other Studies

1 other study available for mianserin and Disorder, Borderline Personality

ArticleYear
Pharmacological management of borderline personality disorder in a pregnant woman with a previous history of alcohol addiction: a case report.
    Clinical drug investigation, 2015, Volume: 35, Issue:11

    Topics: Adult; Alcoholism; Borderline Personality Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Mi

2015